Company: IMNN
Filing Date: 2025-05-27
Form Type: 8-K
Source: 0001641172-25-012395
Chunk: 2

Company: Imunon, Inc.
Filing Date: 2025-05-27
Form: 8-K
Item: Item 1.01
Chunk 2
---
to that certain engagement letter, dated as of May 22, 2025, between the Company and Wainwright (the “ Engagement Letter”).
Pursuant to the Engagement Letter, the Company will pay Wainwright a total cash fee equal to 7.0% of the aggregate gross proceeds of
the Private Placement, as well as certain expenses, including $50,000 for legal fees and expenses, $35,000 for non-accountable expenses,
and the fees for the escrow agent, and Brookline will receive up to 15% of the cash fee. In addition, the Company will issue to Wainwright
warrants (the “ Placement Agent Warrants”) to purchase up to an aggregate of 361,111 shares of Common Stock at an exercise
price equal to $0.5625 per share. The Placement Agent Warrants will have substantially the same terms as the Warrants.

The
Purchase Agreement contains customary representations and warranties of the Company, on the one hand, and the Purchasers, on the other
hand, and customary conditions to closing. In addition, pursuant to the Purchase Agreement, the Company agreed not to issue any shares
of Common Stock or Common Stock equivalents or to file any other registration statement with the SEC (in each case, subject to certain
exceptions) until 30 days after the effective date of the Registration Statement. The Company has also agreed not to effect any Variable
Rate Transaction (as defined in the Purchase Agreement) until one year after the effective date of the Registration Statement (subject
to certain exceptions). Further, as part of the Purchase Agreement, subject to certain exceptions, the Company’s officers and directors
entered into lock-up agreements, pursuant to which they agreed not to sell or otherwise dispose of any shares of Common Stock or securities
convertible, exchangeable or exercisable into shares of Common Stock for a period of 30 days after the effective date of the Registration
Statement (as defined in the Purchase Agreement).

The
foregoing descriptions of terms and conditions of the Purchase Agreement, the Pre-Funded Warrants, the Warrants, the Placement Agent
Warrants and the Registration Rights Agreement do not purport to be complete and are qualified in their entirety by the full text of
the form of the Purchase Agreement, the form of the Pre-Funded Warrant, the form of the Warrant, the form of Placement Agent Warrant
and the form of the Registration Rights Agreement, which are attached hereto as Exhibit 10.1 Exhibit